The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Treatment of fibromyalgia syndrome with gabapentin and pregabalin – A meta-analysis of randomized controlled trials
Abstract
The efficacy of gabapentin (GPT) and pregabalin (PGB) in the treatment of fibromyalgia syndrome (FMS) was assessed. We screened MEDLINE, PsycINFO, SCOPUS, www.clinicaltrials.org, the Cochrane Library (through October 2008), and the reference sections of original studies on GPT/PGB in FMS. Randomized controlled trials (RCTs) on the treatment of FMS with GPT and PGB were analyzed. Six out of 127 RCTs studying 2422 subjects on treatment with GPT (one study) or PGB (five studies) and 1056 subjects on placebo with a median treatment duration of 11 weeks were included into the systematic review. Five studies were suitable for meta-analysis. Effects were summarized using standardized mean differences (SMD). There was strong evidence for a reduction of pain (SMD -0.28, 95% CI -0.36, -0.20; p<0.001), improved sleep (SMD -0.39, 95% CI -0.48, -0.39; p<0.001), and improved health-related quality of life (HRQOL) (SMD -0.30, 95% CI -0.46, -0.15; p<0.001), but not for depressed mood (SMD -0.12, 95% CI -0.30, 0.06; p=0.18). There was strong evidence for a non-substantial reduction of fatigue (SMD -0.16, 95% CI -0.23, -0.09, p<0.001) and of anxiety (SMD -0.18, 95% CI -0.27, -0.10; p<0.001). The external validity of the studies was limited because patients with severe somatic and mental disorders were excluded.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RPT improves behavioural and physiological reactions [59], thus their effects might indirectly affect cognitive reactions (that is, PC).”
From Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: A randomised controlled trial (2011) · cites this paper as [59]
In the citing paper
“Patients with severe somatic comorbidities including inflammatory rheumatic disorders were excluded by all trials.”
From Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome (2010) · cites this paper as [32]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group
van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003) · Spine · doi:10.1097/01.brs.0000065484.95996.af · Cited by 2,180
A Fail-Safe N for Effect Size in Meta-Analysis
Orwin, R. G. (1983) · Journal of Educational Statistics · doi:10.2307/1164923 · Cited by 2,064 · cited 1×
“Therefore we did not perform funnel plots [12] and did not calculate fail-safe Ns [27] to check for a potential publication bias.”
MethodMoher, D., Schulz, K. F., Altman, D. G., & for the CONSORT Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00011 · Cited by 1,426
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
Sackett, D. L. (1989) · CHEST Journal · doi:10.1378/chest.95.2_supplement.2s · Cited by 1,369
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Research works printed but not linked: 1
- Staud, 2008, Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can effect placebo factors., Pain, 232-, 234
Cited by
Sorted by citations
Fibromyalgia: A Clinical Review
Clauw, D. J. (2014) · JAMA · doi:10.1001/jama.2014.3266 · Cited by 1,674
EULAR revised recommendations for the management of fibromyalgia
Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Fluß, E., Choy, E., Kosek, E., Amris, K., Branco, J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209724 · Cited by 1,566
Self-citationThe Development and Psychometric Validation of the Central Sensitization Inventory
Mayer, T. G., Neblett, R., Cohen, H. M., Howard, K. J., Choi, Y. H., Williams, M. J., Perez, Y., & Gatchel, R. J. (2011) · Pain Practice · doi:10.1111/j.1533-2500.2011.00493.x · Cited by 1,017
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 729
Chronic Pain and Mental Health Disorders
Hooten, W. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.029 · Cited by 571
Häuser, W., Klose, P., Langhorst, J., Moradi, B., Steinbach, M., Schiltenwolf, M., & Busch, A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3002 · Cited by 436
Self-citationFitzcharles, M.-A., Ste-Marie, P. A., Goldenberg, D. L., Pereira, J. X., Abbey, S., Choinière, M., Ko, G., Moulin, D. E., Panopalis, P., Proulx, J., et al. (2013) · Pain Research and Management · doi:10.1155/2013/918216 · Cited by 409
Psychological treatments for fibromyalgia: A meta-analysis
Glombiewski, J. A., Sawyer, A. T., Gutermann, J., Koenig, K., Rief, W., & Hofmann, S. G. (2010) · Pain · doi:10.1016/j.pain.2010.06.011 · Cited by 341
Management of functional somatic syndromes and bodily distress
Henningsen, P., Zipfel, S., Sattel, H., & Creed, F. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000484413 · Cited by 335
Bair, M. J., & Krebs, E. E. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202003030 · Cited by 334
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & Rice, A. S. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub3 · Cited by 297
BERNARDY, K., FÜBER, N., KÖLLNER, V., & HÄUSER, W. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100104 · Cited by 266
Self-citationFibromyalgia and related conditions
Clauw, D. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.014 · Cited by 259
Fibromyalgia: from pathophysiology to therapy
Schmidt‐Wilcke, T., & Clauw, D. J. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.98 · Cited by 231
Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome
Häuser, W., Petzke, F., & Sommer, C. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.01.002 · Cited by 216
Self-citationGabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
Nüesch, E., Häuser, W., Bernardy, K., Barth, J., & Jüni, P. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201249 · Cited by 225
Self-citationMease, P. J., HANNA, S., Frakes, E. P., & Altman, R. D. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100759 · Cited by 175
Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology
Kia, S., & Choy, E. (2017) · Biomedicines · doi:10.3390/biomedicines5020020 · Cited by 166
Deng, M., Chen, S., & Pan, H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03047-y · Cited by 145
Psychology of Chronic Pelvic Pain: Prevalence, Neurobiological Vulnerabilities, and Treatment
TILL, S. R., AS-SANIE, S., & SCHREPF, A. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000412 · Cited by 134
Marlow, N. M., Bonilha, H. S., & Short, E. B. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00562.x · Cited by 124
Current and Emerging Pharmacotherapy for Fibromyalgia
Tzadok, R., & Ablin, J. N. (2020) · Pain Research and Management · doi:10.1155/2020/6541798 · Cited by 122
“A meta-analysis of randomized controlled trials regarding both pregabalin and gabapentin further emphasized their effect in improving pain, fatigue, sleep, and overall quality of life, in addition to their lack of effect on depressive symptoms and relatively nonsubstantial effect on anxiety [22].”
BackgroundCombination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial
Gilron, I., Chaparro, L. E., Tu, D., Holden, R. R., Milev, R. V., Towheed, T., Dumerton-Shore, D., & Walker, S. L. (2016) · Pain · doi:10.1097/j.pain.0000000000000558 · Cited by 124
An update on pharmacotherapy for the treatment of fibromyalgia
Calandre, E. P., Rico‐Villademoros, F., & Slim, M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1047343 · Cited by 119
Healthy Aging in Relation to Chronic Pain and Quality of Life in Europe
Leadley, R. M., Armstrong, N., Reid, K. J., Allen, A., Misso, K., & Kleijnen, J. (2013) · Pain Practice · doi:10.1111/papr.12125 · Cited by 110
Nishiyori, M., Nagai, J., Nakazawa, T., & Ueda, H. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.080 · Cited by 110
Psychosomatic factors in pruritus
Tey, H. L., Wallengren, J., & Yosipovitch, G. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.11.004 · Cited by 113
Glombiewski, J. A., Bernardy, K., & Häuser, W. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/962741 · Cited by 106
Self-citationCombination pharmacotherapy for the treatment of fibromyalgia in adults
Thorpe, J. B., Shum, B., Moore, A., Wiffen, P. J., & Gilron, I. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010585.pub2 · Cited by 106
Current pharmacological treatments for tinnitus
Langguth, B., & Elgoyhen, A. B. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.739608 · Cited by 100
Gabapentin for fibromyalgia pain in adults
Cooper, T. E., Derry, S., Wiffen, P. J., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012188.pub2 · Cited by 92
Häuser, W., Eich, W., Herrmann, M., Nutzinger, D. O., Schiltenwolf, M., & Henningsen, P. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0383 · Cited by 88
Self-citationFibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome.
Smith, H. S., Harris, R. E., & Clauw, D. J. (2011) · PubMed · Cited by 88
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-7020-4086-3.00033-3 · Cited by 86
Fibromyalgia Syndrome in Need of Effective Treatments
Theoharides, T. C., Tsilioni, I., Arbetman, L., Panagiotidou, S., Stewart, J. M., Gleason, R. M., & Russell, I. J. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.227298 · Cited by 95
Fibromyalgia: A Clinical Update
Hawkins, R. A. (2013) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2013.034 · Cited by 85
Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION
Dworkin, R. H., Turk, D. C., Katz, N. P., Rowbotham, M. C., Peirce‐Sandner, S., Cerny, I., Clingman, C. S., Eloff, B. C., Farrar, J. T., Kamp, C., et al. (2010) · Pain · doi:10.1016/j.pain.2010.11.008 · Cited by 86
Alda, M., Luciano, J. V., Andrés, E., Serrano-Blanco, A., Rodero, B., del Hoyo, Y. L., Roca, M., Moreno, S., Magallón, R., & García-Campayo, J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3496 · Cited by 77
“RPT improves behavioural and physiological reactions [59], thus their effects might indirectly affect cognitive reactions (that is, PC).”
BackgroundGris, G., Portillo-Salido, E. F., Aubel, B., Darbaky, Y., Deseure, K. R., Vela, J. M., Merlos, M., & Zamanillo, D. (2016) · Scientific Reports · doi:10.1038/srep24591 · Cited by 76
Medikamentöse Therapie des Fibromyalgiesyndroms
Sommer, C., Häuser, W., Alten, R., Petzke, F. W., Späth, M., Tölle, T. R., Üçeyler, N., Winkelmann, A., Winter, E., & Bär, K. (2012) · Der Schmerz · doi:10.1007/s00482-012-1172-2 · Cited by 79
Self-citationPharmacotherapy of fibromyalgia
Mease, P. J., Dundon, K. M. W., & Sarzi‐Puttini, P. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.01.015 · Cited by 75
Chronic Opioid Use in Fibromyalgia Syndrome
Painter, J. T., & Crofford, L. J. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3182863447 · Cited by 74
Choy, E., Marshall, D. A. S., Gabriel, Z., Mitchell, S., Gylee, E., & Dakin, H. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.06.003 · Cited by 66
Peng, P. (2012) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0b013e31824f6629 · Cited by 64
Management of Fibromyalgia Syndrome in 2016
Okifuji, A., Gao, J., Bokat, C. E., & Hare, B. D. (2016) · Pain Management · doi:10.2217/pmt-2016-0006 · Cited by 66
Peripheral and Central Mechanisms of Fatigue in Inflammatory and Noninflammatory Rheumatic Diseases
Staud, R. M. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0277-z · Cited by 64
Sleep Disturbance and Chronic Widespread Pain
McBeth, J., Wilkie, R., Bedson, J., Chew-Graham, C. A., & Lacey, R. J. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-014-0469-9 · Cited by 59
Approach to Diagnosis and Management of Chronic Pelvic Pain in Women
Till, S. R., Nakamura, R., Schrepf, A., & As‐Sanie, S. (2022) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2022.02.006 · Cited by 60
Gale, J. D., & Houghton, L. A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00028 · Cited by 58
New Concepts in Pain Research and Pain Management of the Rheumatic Diseases
Goldenberg, D. L., Clauw, D. J., & Fitzcharles, M. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.04.005 · Cited by 58
Fibromyalgia and Inflammation: Unrevealing the Connection
García‐Domínguez, M. (2025) · Cells · doi:10.3390/cells14040271 · Cited by 69
New Insights into the Pathophysiology and Treatment of Fibromyalgia
Schmidt‐Wilcke, T., & Diers, M. (2017) · Biomedicines · doi:10.3390/biomedicines5020022 · Cited by 57
Homeopathic Treatments in Psychiatry
Davidson, J. R. T., Crawford, C. C., Ives, J. A., & Jonas, W. B. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06580 · Cited by 56
Pharmacological Management of Chronic Pelvic Pain in Women
Carey, E. T., Till, S. R., & As‐Sanie, S. (2017) · Drugs · doi:10.1007/s40265-016-0687-8 · Cited by 57
Singh, L., Kaur, A., Bhatti, M. S., & Bhatti, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02805-5 · Cited by 55
Fibromyalgia Syndrome: A Discussion of the Syndrome and Pharmacotherapy
Smith, H. S., & Barkin, R. L. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181df8e1b · Cited by 55
Luciano, J. V., Martínez, N., Peñarrubia-María, M. T., Fernández-Vergel, R., García-Campayo, J., Verduras, C., Blanco, M. E., Jiménez, M., Ruiz, J. M., del Hoyo, Y. L., et al. (2011) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31820b131c · Cited by 65
The Role of Antipsychotics in the Management of Fibromyalgia
Calandre, E. P., & Rico‐Villademoros, F. (2012) · CNS Drugs · doi:10.2165/11597130-000000000-00000 · Cited by 49
Management of Fibromyalgia Syndrome: Review of Evidence
Okifuji, A., & Hare, B. D. (2013) · Pain and Therapy · doi:10.1007/s40122-013-0016-9 · Cited by 49
Moffett, Fray, & Kubat, I. I. (2012) · Journal of Pain Research · doi:10.2147/jpr.s35076 · Cited by 50
Häuser, W., Hayo, S., Biewer, W., Gesmann, M., Kühn-Becker, H., Petzke, F. W., von Wilmoswky, H., & Langhorst, J. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181d92a6c · Cited by 48
Self-citationLuciano, J. V., D’Amico, F., Cerdà-Lafont, M., Peñarrubia-María, M. T., Knapp, M., Cuesta-Vargas, A. I., Serrano-Blanco, A., & García-Campayo, J. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0451-y · Cited by 48
Pharmacological Treatment of Fibromyalgia Syndrome
Staud, R. M. (2009) · Drugs · doi:10.2165/11530950-000000000-00000 · Cited by 44
Pregabalin for the management of fibromyalgia syndrome
Boomershine, C. S. (2010) · Journal of Pain Research · doi:10.2147/jpr.s7884 · Cited by 44
Fibromyalgia: evolving concepts over the past 2 decades
Fitzcharles, M., Ste‐Marie, P. A., & Pereira, J. X. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121414 · Cited by 48
Nishiyori, M., Uchida, H., Nagai, J., Araki, K., Mukae, T., Kishioka, S., & Ueda, H. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-69 · Cited by 43
2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome
Fitzcharles, M., Ste‐Marie, P. A., Goldenberg, D. L., Abbey, S. E., Choinière, M., Ko, G. D., Moulin, D. E., Panopalis, P., Proulx, J., & Shir, Y. (2012) · Cited by 39
Pharmacotherapy of fibromyalgia
Traynor, L. M., Thiessen, C. N., & Traynor, A. P. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100322 · Cited by 39
Combining Cognitive-Behavioral Therapy and Milnacipran for Fibromyalgia
Ang, D. C., Jensen, M. P., Steiner, J. L., Hilligoss, J., Gracely, R. H., & Saha, C. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31827a784e · Cited by 37
‘This constant being woken up is the worst thing’ – experiences of sleep in fibromyalgia syndrome
Theadom, A., & Cropley, M. (2010) · Disability and Rehabilitation · doi:10.3109/09638281003797331 · Cited by 36
Kim, S. C., Landon, J. E., & Solomon, D. H. (2013) · Arthritis Care & Research · doi:10.1002/acr.22071 · Cited by 35
Nagakura, Y., Miwa, M., Yoshida, M., Miura, R., Tanei, S., Tsuji, M., & Takeda, H. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172716 · Cited by 35
Milnacipran for the Treatment of Fibromyalgia
Gupta, H., Girma, B., Jenkins, J. S., Kaufman, S. E., Lee, C. A., & Kaye, A. D. (2021) · Health Psychology Research · doi:10.52965/001c.25532 · Cited by 35
Weighing the balance: how analgesics used in chronic pain influence sleep?
Bohra, M., Kaushik, C., Temple, D., Chung, S. A., & Shapiro, C. M. (2014) · British Journal of Pain · doi:10.1177/2049463714525355 · Cited by 33
An evidence-based review of pregabalin for the treatment of fibromyalgia
Arnold, L. M., Choy, E., Clauw, D. J., Oka, H., Whalen, E., Semel, D., Pauer, L., & Knapp, L. E. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1450743 · Cited by 36
Fibromyalgia: From treatment to rehabilitation
Imamura, M., Cassius, D. A., & Fregni, F. (2009) · European Journal of Pain Supplements · doi:10.1016/j.eujps.2009.08.011 · Cited by 33
Zhang, K., Wang, L., Zhang, Z.-H., Zhang, D., Lin, X., Meng, T., & Qi, F. (2022) · Journal of Pain Research · doi:10.2147/jpr.s384215 · Cited by 32
Yoo, H. B., Ost, J., Joos, W., Havenbergh, T. V., Ridder, D. D., & Vanneste, S. (2017) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000552 · Cited by 34
Kim, S. H., Lee, Y., Lee, S., & Mun, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074099 · Cited by 30
Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol
Busse, J. W., Ebrahim, S., Connell, G. P., Coomes, E. A., Bruno, P. A., Malik, K., Torrance, D., Ngo, T., Kirmayr, K., Avrahami, D., et al. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-18 · Cited by 30
Jamison, R. N., Edwards, R. R., Curran, S., Wan, L., Ross, E. L., Gilligan, C. J., & Gozani, S. N. (2021) · Journal of Pain Research · doi:10.2147/jpr.s316371 · Cited by 31
Gilron, I., Robb, S., Tu, D., Holden, R. R., Towheed, T., Ziegler, D., Wang, L., Milev, R. V., & Gray, C. (2020) · Pain · doi:10.1097/j.pain.0000000000002028 · Cited by 27
Pharmacotherapy in fibromyalgia (FM) — Implications for the underlying pathophysiology
Schmidt‐Wilcke, T., & Clauw, D. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.002 · Cited by 25
Balogh, M., Zádor, F., Zádori, Z., Shaqura, M. A., Király, K. P., Mohammadzadeh, A., Varga, B. T., Lázár, B., Mousa, S. A., Hosztafi, S., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00347 · Cited by 26
Pregabalin for the treatment of fibromyalgia
Smith, M. T., & Moore, B. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.687373 · Cited by 24
Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis
Migliorini, F., Maffulli, N., Knobe, M., Tenze, G., Aljalloud, A., & Colarossi, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-16146-x · Cited by 25
“Fibromyalgia – are there any new approaches?”
Martinez, J. E., & Guimarães, I. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101933 · Cited by 30
The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective
Lloyd, A., Boomershine, C. S., Choy, E., Chandran, A., & Zlateva, G. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.660254 · Cited by 23
Pharmacological and Interventional Management of Pain After Whiplash Injury
Curatolo, M. (2016) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2016.6906 · Cited by 22
Wodehouse, T., Poply, K., Ramaswamy, S., Snidvongs, S., Bourke, J. H., Tahir, H., Ullrich, K., & Mehta, V. (2018) · British Journal of Pain · doi:10.1177/2049463718776336 · Cited by 22
Brummett, C. M., & Clauw, D. J. (2011) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32834a1091 · Cited by 21
Fibromyalgia Syndrome: Novel Therapeutic Targets
Ablin, J. N., & Häuser, W. (2016) · Pain Management · doi:10.2217/pmt-2016-0007 · Cited by 21
Self-citationThe Black Book of Psychotropic Dosing and Monitoring
DeBattista, C., & Schatzberg, A. F. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4493 · Cited by 23
Cheng, D. K.-Y., Lai, K. S. P., Pico-Espinosa, O. J., Rice, D. B., Chung, C., Modarresi, G., & Sud, A. (2021) · Pain Medicine · doi:10.1093/pm/pnab248 · Cited by 21
Fibromyalgia Syndrome: A Discussion of the Syndrome and Pharmacotherapy
Smith, H. S., & Barkin, R. L. (2011) · Disease-a-Month · doi:10.1016/j.disamonth.2011.02.001 · Cited by 20
Psychopharmacology of chronic pain
Ciaramella, A. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00019-8 · Cited by 20
Cellular mechanisms underlying central sensitization in a mouse model of chronic muscle pain
Lin, Y., Yang, Z.-S., Wong, W.-Y., Lin, S.-C., Wang, S., Chen, S., Cheng, J., Lü, H., & Lien, C. (2022) · eLife · doi:10.7554/elife.78610 · Cited by 24
Mind-body therapy for treating fibromyalgia: a systematic review
Steen, J. P., Kannan, V., Zaidi, A., Cramer, H., & Ng, J. Y. (2024) · Pain Medicine · doi:10.1093/pm/pnae076 · Cited by 34
Can a bibliometric indicator predict the success of an analgesic?
Kissin, I. (2010) · Scientometrics · doi:10.1007/s11192-010-0320-7 · Cited by 19
Metadata
- Authors
- Häuser, W., Bernardy, K., Üçeyler, N., & Sommer, C.
- Affiliations
- Klinikum Saarbrücken (DE)
- Saarland University (DE)
- University of Würzburg (DE)
- Corresponding author
- Häuser, Winfried
- Venue
- Pain
- Published
- 2009-09
- Volume
- 145
- Issue
- 1
- Pages
- 69-81
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2023541450
- Cited by
- 243
- References
- 43
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 7 · 2018: 10 · 2017: 13 · 2016: 16 · 2015: 14 · 2014: 15 · 2013: 23 · 2012: 24
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pain (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Cilag
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- fibromyalgia, gabapentin, pregabalin, analgesia, sleep quality, health-related quality of life, fatigue, anxiety, depressive mood, antiepileptic drugs
- MeSH terms
- Pregabalin, Gabapentin, Amines, Analgesics, Calcium Channel Blockers, Cyclohexanecarboxylic Acids, Fibromyalgia, gamma-Aminobutyric Acid, Humans, Reproducibility of Results, Randomized Controlled Trials as Topic, Databases, Bibliographic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review